Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
Composition and Quality Validation of the Peptide Matrix To support rigorous, repeatable analytical trials, each constituent peptide in the blend is synthesized to exact structural specifications before integration: Mod GRF (Modified GRF 1-29 / CJC-1295 No DAC): A 29-amino-acid tetrasubstituted peptide analog optimized for structural stability against rapid blood plasma dipeptidyl peptidase-4 (DPP-4) cleavage
The table below is our read on what each major player is actually building
The trial is listed as Completed on ClinicalTrials.gov, with a primary completion date of April 6, 2026
You can also log in to your account and view your tracking number under the Orders tab
US$ 22.74
US$ 27.34
US$ 26.84
US$ 23.71
